IP Library › Granted Patent US 8,097,607
Granted Patent B2
US 8,097,607 · App. 10/668,792 · Granted Jan 17, 2012

Low dose rifalazil compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,097,607
App. No.
10/668,792
Granted
Jan 17, 2012
Kind
B2
Abstract

The invention features low-dosage rifalazil compositions which are useful for the treatment of bacterial infections.

Claims (4)

1. A pharmaceutical composition comprising a unit dosage form of rifalazil in an amount of 0.25 mg.

2. A pharmaceutical composition according to claim 1 , wherein said unit dosage is a tablet, pill, capsule, or caplet.

3. A pharmaceutical composition comprising a unit dosage form of rifalazil in an amount between 0.2 and 0.7 mg.

4. The pharmaceutical composition of claim 3 , wherein said unit dosage is a tablet, pill, capsule, or caplet.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2008
From: FINN JR.,JOSEPH F., AS ASSIGNEE FOR THE BENEFIT OF CREDITORS OF ACTIVBIOTICS, INC.
To: ACTIVBIOTICS PHARMA LLC
Reel/Frame 020866/0584 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2008
From: HORIZON TECHNOLOGY FUNDING COMPANY LLC
To: ACTIVBIOTICS, INC.
Reel/Frame 020835/0427 →